NICE turns down Shire’s Revestive for bowel condition
The National Institute for Health and Care Excellence has published draft guidelines rejecting NHS funding for Shire’s Revestive as a treatment for short bowel syndrome (SBS).
Read More
Tag: Short Bowel Syndrome
EU allows paediatric use of Shire’s Restive
European regulators have approved the use of Shire’s Restive in children with short bowel syndrome (SBS), a rare and potentially life-threatening gastrointestinal condition.
Read More
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
